Clinical Trials Browser

Phase 3 × OTHER × Nasopharangeal Cancer × Clear all

NCT07235319 2025-11-19

PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Salvage Locoregional Radiotherapy in De Novo Metastatic NPC

Phase 3 Recruiting

Nasopharangeal Cancer